Introduction: Many People Think mRNA Has Already Succeeded — But It’s Just Getting Started Ask most people what mRNA is, and you’ll probably hear answers like: COVID-19 vaccines Moderna Pfizer The breakthrough technology of the pandemic And they wouldn’t be wrong. COVID-19 vaccines represent one of the most successful commercial applications of mRNA technology in history. However, if you ask scientists working in RNA therapeutics, gene therapy, or drug delivery, you may hear

Introduction How Amino Acids Enhance LNP mRNA Delivery: A New Direction for mRNA Therapeutics Over the past few years, lipid nanoparticles (LNPs) have become the cornerstone of modern mRNA therapeutics. From COVID-19 mRNA vaccines to cancer immunotherapy, rare disease treatment, and gene editing, LNPs are now one of the most important delivery platforms for nucleic acid medicines. But anyone who has worked in drug delivery knows a frustrating reality: An LNP system that perfo

Introduction: Are We Missing the Most Important Piece? Over the past few years, mRNA therapeutics has rapidly expanded—from vaccines to cancer immunotherapy, gene editing, and protein replacement. But if you’ve actually worked in this space, you’ve probably had this intuition: Often, it’s not that your design isn’t good enough—it’s that delivery just doesn’t work. So we optimize: Codon usage Nucleoside modifications Cap and poly(A) tail LNP formulations All of these matter. B

Introduction Following the success of COVID-19 vaccines, mRNA technology has rapidly emerged as one of the most important platforms in modern biotechnology . By enabling human cells to temporarily produce therapeutic proteins, mRNA therapeutics are being explored across a wide range of medical applications, including: Vaccines Cancer immunotherapy Protein replacement therapies Gene editing (CRISPR delivery) However, mRNA molecules are inherently fragile. Without protection,